Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Cycling Union Denies Cover-up of Armstrong Positive Drug Test

Seven-Time Tour de France Winner Lance Armstrong
Seven-time Tour de France winner Lance Armstrong. Photographer: Gabriel Bouys/AFP/Getty Images

The International Cycling Union denied allegations made by former U.S. Postal Service team rider Tyler Hamilton that record seven-time Tour de France winner Lance Armstrong had covered up a positive doping test.

The governing body, known as UCI, said it has “never altered or hidden the results of a positive test” in a statement released today.

Hamilton’s allegations were shown last night on CBS Corp.’s “60 Minutes” program. The former Olympic champion alleged that Armstrong got preferential treatment from UCI officials after failing a test for a performance-enhancing drug in 2001. Hamilton, 40, said he saw Armstrong doping on numerous occasions and that the rider and leaders of the U.S. Postal Service cycling team encouraged the use of performance-enhancing substances.

“The allegations of Mr. Tyler Hamilton are completely unfounded,” UCI said in its statement. “The UCI can only express its indignation at this latest attempt to damage the image of cycling by a cyclist who has not hesitated to abuse the trust of all followers of cycling on several occasions in the past. At no time did he see fit to inform the UCI of the events he claims to have witnessed ten years ago, and which he is now using in his attempt to harm the UCI.”

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.